Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
198 Leser
Artikel bewerten:
(1)

Vector Control Market worth $29.80 billion by 2029 - Exclusive Report by MarketsandMarkets

Finanznachrichten News

DELRAY BEACH, Fla., Nov. 13, 2024 /PRNewswire/ -- The vector control market is estimated at USD 21.72 billion in 2024 and is projected to reach USD 29.80 billion by 2029, at a CAGR of 6.5% from 2024 to 2029, according to a report published by MarketsandMarkets.

MarketsandMarkets Logo

The vector control market is experiencing strong growth. The vector-borne diseases of malaria, dengue, and Zika have been influencing this growth, but rising awareness concerning public health has also played a vital role. Governments and other health agencies are making all-out efforts to avoid the vectors that cause diseases; efforts are being placed for an integrated pest management technique that combines traditional practices with new advanced technologies like AI-based surveillance and biological agents. Regulatory changes towards more environment-friendly practices are driving the need for novel, eco-friendly solutions. Increased attention to public health, along with technological innovations, is likely to support further market growth in the near future. Increased urbanization and population density provide supportive conditions for the proliferation of vectors and an increased need for effective control measures.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=265146798

Browse in-depth TOC on "Vector Control Market"

150 - Tables
80 - Figure
300 - Pages

The residential segment hold the highest market share in the end-use sector share of the vector control market.

The residential segment holds the highest market share largest market share, driven by the ever-growing need to effectively control pests within homes in order to avoid diseases that are caused by vectors. With widening urban populations and more people recognizing health dangers associated with mosquitoes, rodents, and many other pest organisms, the demand for vector control solutions in residential has expanded. The demand for eco-friendly vector control products Growing demand from consumers has increased the adoption of biological and non-chemical vector control options in the residential sector.

The biological segment is growing at a significant CAGR in the vector control market during the forecasted period 2024-2029.

The biological sector of the vector control market is developing rapidly with the increasing demand for eco-friendly and sustainable pest management solutions. The environment now largely becomes the target of a harnessed pesticide that would be developed to minimize damage towards non-target species as well as ecosystems when rising concerns regarding the environmental impact of chemical pesticides arise both from consumers and regulatory bodies. Anticimex (Sweden) offers Bti treatment. Bti represents a bacterium that kills mosquito larvae without affecting people, pets, or other animals.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265146798

Based on region, Europe has a significant share in the vector control market.

Europe holds a significant market share for vector control mainly because of the stringent public health policies and more awareness of diseases caused through vectors. This region has also high investments in effective controls and encompasses several proactive measures in the management of pests like mosquitoes and ticks, which cause diseases like Lyme disease and West Nile virus. Supports are given in building and using new pest management technologies, for instance, biological control and integrated pest management methods. European Centre for Disease Control (ECDC) monitors vector-borne diseases like West Nile fever and tick-borne encephalitis and has made available risk assessments about outbreaks within the EU and its overseas regions.

The report profiles key playerssuch as BASF SE (Germany), Rentokil Initial Plc (UK), Sumitomo Chemical Co., Ltd. (Japan), Syngenta Group (Switzerland), FMC Corporation (US), Ecolab (US), Rollins Inc. (US), Anticimex (Sweden), UPL (India), Neogen Corporation (US), Senestech, Inc. (US), Environmental Science U.S. Inc. (US), Bell Laboratories Inc. (US), Pelgar International (UK), S. C. Johnson & Son, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=265146798

Browse Adjacent Reports @ Agriculture Industry Market Research Reports & Consulting

Related Reports:

Rodenticides Market by Type (Chemical, Mechanical, Biological, And Software & Services), Mode of Application (Pellets, Spray, And Powder), End Use (Agriculture, Warehouses, Urban Centres), Rodent Type, and Region-Global Forecast to 2029

Pest Control Market by Control Method (Chemical, Mechanical, Biological, Software & Services), Pest Type (Insects, Rodents, Termites, Wildlife), Mode of Application (Sprays, Traps, Baits, Pellets, Powder), Application and Region - Global Forecast to 2028

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/vector-control-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/vector-control.asp

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/vector-control-market-worth-29-80-billion-by-2029--exclusive-report-by-marketsandmarkets-302303747.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.